Loading…
Loading…
Arkema S.A.
GLEIF (checked 2026-08-31) has an ISSUED LEI for ARKEMA (9695000EHMS84KKP2785, jurisdiction FR) with parent_reported: false and is_own_ultimate_parent: false — i.e. GLEIF has no parent on file, consistent with Arkema S.A. being the ultimate group holding company rather than a subsidiary (GLEIF's own subsidiary, ARKEMA FRANCE, LEI 96950026BLIV09FMSM49, correctly reports ARKEMA as its direct/ultimate parent). Arkema was spun off from Total S.A. in 2006 (shares distributed pro-rata to Total shareholders) and has traded on Euronext Paris since; no single institutional shareholder with a controlling or blocking stake was identified in Arkema's own investor-relations disclosures or in secondary shareholder-structure coverage. Employees hold roughly 9% of share capital via employee share-ownership plans (per 2024 capital-increase reporting) — the largest identifiable single category, but not a controlling stake. Exact institutional-holder percentages are disclosed only as chart visuals in Arkema's Universal Registration Document, not extractable via text fetch, so no fabricated percentage is recorded here.
Named counterparties identified by open-source research and written only where a primary source states the relationship — never inferred from sector or co-mention. 1 supplier. This is a partial view: it covers the relationships we could evidence, not the company's full supply base.
Nippon Shokubai and Arkema formed a joint venture to mass-produce LiFSI battery-electrolyte salt at Arkema's Pierre-Bénite (FR) site, per Arkema's own newsroom: Arkema contributes fluorochemicals expertise, Nippon Shokubai contributes industrial-scale high-purity LiFSI production know-how. Recorded as supplier (of process technology into the JV) rather than customer since Nippon Shokubai is not a buyer of Foranext output.
Scope. Absence of a counterparty here is not evidence that none exists — most commercial sourcing is confidential and never becomes public. Rows without a share figure mean no share was disclosed, not that the relationship is small.
Every exposure is read as a buyer dependency; the top 2 are its binding chokepoints.
As a buyer, policy pressure across its consumed materials is flat.
Descriptive trend in official policy actions on this company’s materials — a policy-pressure trend, not a price or trading signal. No forward probability is implied. Direction is measured on actions we have discovered, and discovery lags events: where the recent window is too thin to support a calm reading, the row says coverage-limited instead of easing.
No actions in the register have named or swept this company in the last 24 months.